NYSE:PKI - PerkinElmer Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $152.77
  • Forecasted Upside: -11.85 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$173.32
▲ +2.93 (1.72%)

This chart shows the closing price for PKI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New PerkinElmer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PKI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PKI

Analyst Price Target is $152.77
▼ -11.85% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for PerkinElmer in the last 3 months. The average price target is $152.77, with a high forecast of $193.00 and a low forecast of $49.00. The average price target represents a -11.85% upside from the last price of $173.32.

This chart shows the closing price for PKI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 8 contributing investment analysts is to buy stock in PerkinElmer. This rating has held steady since October 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 8 buy ratings
  • 7 hold ratings
  • 0 sell ratings
4/27/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 0 sell ratings
10/24/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
1/22/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/22/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/21/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/19/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/9/2021Royal Bank of CanadaBoost Price TargetOutperform$48.00 ➝ $49.00Medium
7/27/2021Evercore ISIReiterated RatingOutperform$174.00 ➝ $170.86Medium
7/27/2021Robert W. BairdReiterated RatingOutperform$150.00 ➝ $172.11Medium
6/15/2021Wolfe ResearchUpgradeMarket Perform ➝ OutperformLow
2/3/2021CitigroupBoost Price Target$150.00 ➝ $155.00High
1/7/2021Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$140.00 ➝ $175.00N/A
12/11/2020Smith Barney CitigroupBoost Price Target$140.00 ➝ $150.00Low
12/2/2020The Goldman Sachs GroupInitiated CoverageBuy$160.00Low
11/12/2020The Goldman Sachs GroupInitiated CoverageBuy$50.00Low
11/9/2020KeyCorpInitiated CoverageSector Weight ➝ Sector Weight$150.00Medium
11/9/2020Needham & Company LLCBoost Price TargetBuy$139.00 ➝ $193.00High
10/29/2020Smith Barney CitigroupBoost Price Target$120.00 ➝ $140.00Low
10/29/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$130.00 ➝ $140.00Low
10/29/2020Robert W. BairdBoost Price TargetOutperform$137.00 ➝ $151.00High
9/11/2020Needham & Company LLCUpgradeHold ➝ Buy$139.00High
8/10/2020BMO Capital MarketsBoost Price TargetOutperform$44.00 ➝ $45.00Low
7/29/2020JPMorgan Chase & Co.Boost Price TargetNeutral$85.00 ➝ $105.00High
7/29/2020Stifel NicolausBoost Price TargetBuy$95.00 ➝ $125.00High
7/29/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$105.00 ➝ $130.00High
7/29/2020CfraUpgradeHold ➝ BuyHigh
7/13/2020Needham & Company LLCInitiated CoverageHoldHigh
5/7/2020UBS GroupBoost Price TargetNeutral$95.00 ➝ $96.00Low
5/6/2020Robert W. BairdBoost Price TargetOutperform$94.00 ➝ $99.00Low
5/6/2020CfraLower Price TargetHold$100.00 ➝ $94.00Low
5/6/2020JPMorgan Chase & Co.Boost Price TargetNeutral$80.00 ➝ $85.00Medium
4/28/2020UBS GroupLower Price TargetNeutral$100.00 ➝ $95.00Low
4/20/2020CitigroupBoost Price TargetNeutral$70.00 ➝ $85.00Low
4/2/2020JPMorgan Chase & Co.Lower Price TargetOverweight$49.00 ➝ $45.00High
4/2/2020Stifel NicolausLower Price TargetBuy$102.00 ➝ $80.00Low
3/30/2020Wells Fargo & CompanyLower Price TargetEqual Weight$100.00 ➝ $80.00Low
3/26/2020BarclaysLower Price TargetEqual Weight$100.00 ➝ $94.00Medium
3/20/2020CitigroupLower Price TargetNeutral$100.00 ➝ $70.00Low
1/28/2020UBS GroupBoost Price TargetNeutral$92.00 ➝ $100.00High
1/14/2020TD SecuritiesBoost Price TargetBuy$54.00 ➝ $56.00Medium
1/7/2020Wells Fargo & CompanyInitiated CoverageEqual Weight$105.00Low
1/6/2020CitigroupInitiated CoverageNeutral$100.00Medium
1/3/2020Needham & Company LLCInitiated CoverageHold$79.00Medium
1/2/2020Evercore ISIUpgradeIn-Line ➝ Outperform$89.00 ➝ $114.00High
11/21/2019Stifel NicolausReiterated RatingBuyLow
11/14/2019Stifel NicolausInitiated CoverageBuy$102.00High
11/5/2019Raymond JamesReiterated RatingBuy ➝ Average$51.00Low
10/31/2019Needham & Company LLCReiterated RatingHoldHigh
10/31/2019Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$104.00 ➝ $89.00High
10/18/2019UBS GroupLower Price TargetNeutral$101.00 ➝ $92.00Low
9/26/2019Bank of AmericaUpgradeNeutral ➝ Buy$105.00Low
7/30/2019UBS GroupBoost Price TargetNeutral$99.00 ➝ $101.00High
7/19/2019Wood & CompanyReiterated RatingAverage$49.00Medium
7/10/2019Raymond JamesInitiated CoverageOutperformLow
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow
5/3/2019Royal Bank of CanadaReiterated RatingHold$41.00Low
4/9/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy$115.00High
2/2/2019UBS GroupSet Price TargetHold$92.00Low
2/1/2019Piper Jaffray CompaniesBoost Price TargetOverweight$104.00Medium
1/16/2019DesjardinsReiterated RatingBuy ➝ Average$45.00Low
1/10/2019CIBCReiterated RatingBuy ➝ Average$44.50Medium
1/6/2019CowenReiterated RatingHold$85.00Low
1/3/2019Morgan StanleyLower Price TargetOverweight ➝ Overweight$100.00 ➝ $86.00Low
1/2/2019Needham & Company LLCInitiated CoverageHold ➝ Hold$79.00High
11/2/2018Janney Montgomery ScottDowngradeBuy ➝ NeutralMedium
10/10/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$95.00 ➝ $100.00High
10/9/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$100.00Low
9/10/2018Deutsche Bank AktiengesellschaftBoost Price TargetHold ➝ Hold$88.00 ➝ $93.00Low
9/5/2018BarclaysUpgradeUnderweight ➝ Equal Weight$79.00 ➝ $90.00Low
8/30/2018Cleveland ResearchUpgradeNeutral ➝ BuyMedium
8/2/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$83.00 ➝ $86.00Low
8/2/2018CowenReiterated RatingHold$85.00Low
8/2/2018Robert W. BairdReiterated RatingBuy$89.00Low
8/2/2018BarclaysBoost Price TargetUnderweight ➝ Underweight$73.00 ➝ $79.00High
8/2/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$90.00 ➝ $95.00High
5/1/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$85.00 ➝ $90.00High
5/1/2018Bank of AmericaLower Price TargetNeutral ➝ Hold$86.00 ➝ $83.00High
5/1/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$88.00 ➝ $82.00High
5/1/2018Janney Montgomery ScottLower Price TargetBuy ➝ Fair Value$92.00 ➝ $73.36High
4/11/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$89.00 ➝ $85.00Low
4/9/2018Deutsche Bank AktiengesellschaftLower Price TargetHold ➝ Hold$85.00 ➝ $80.00Low
1/26/2018BarclaysBoost Price TargetUnderweight ➝ Underweight$69.00 ➝ $73.00Low
1/26/2018CowenReiterated RatingHold$84.00Low
1/26/2018Robert W. BairdReiterated RatingBuy$88.00Medium
1/3/2018Evercore ISIInitiated CoverageIn-Line$77.00Low
12/19/2017Bank of AmericaUpgradeUnderperform ➝ Neutral$78.00Low
11/3/2017Morgan StanleyBoost Price TargetOverweight$77.00 ➝ $78.00N/A
11/3/2017Robert W. BairdBoost Price TargetOutperform$75.00 ➝ $78.00N/A
10/20/2017Jefferies Financial GroupReiterated RatingHold$70.00N/A
10/20/2017Robert W. BairdReiterated RatingBuy$72.00N/A
10/6/2017Morgan StanleyReiterated RatingOverweight$79.00 ➝ $77.00N/A
9/26/2017The Goldman Sachs GroupReiterated RatingNeutral ➝ Neutral$67.00Low
9/26/2017CitigroupReiterated RatingBuy$74.00 ➝ $80.00Low
9/1/2017CowenReiterated RatingHold$70.00Low
8/7/2017CitigroupBoost Price TargetBuy$67.00 ➝ $74.00Medium
8/4/2017Piper Jaffray CompaniesReiterated RatingBuy$81.00Medium
7/25/2017Piper Jaffray CompaniesBoost Price TargetOverweight$80.00Medium
7/16/2017Cantor FitzgeraldReiterated RatingHoldLow
7/13/2017Wells Fargo & CompanyInitiated CoverageMarket Perform ➝ Market Perform$72.00Low
7/10/2017Morgan StanleyReiterated RatingOverweight$73.00 ➝ $79.00Low
6/22/2017Evercore ISIReiterated RatingIn-Line$62.50 ➝ $68.00Low
6/21/2017Cantor FitzgeraldReiterated RatingNeutralLow
6/20/2017Jefferies Financial GroupReiterated RatingHold$58.00 ➝ $69.00Medium
6/20/2017CowenReiterated RatingMarket Perform$61.00 ➝ $70.00Low
6/19/2017Cantor FitzgeraldSet Price TargetHold$65.00High
5/15/2017Jefferies Financial GroupReiterated RatingHold$49.00Low
5/15/2017Cantor FitzgeraldReiterated RatingHold$65.00Low
5/6/2017BarclaysSet Price TargetSell$55.00Low
5/5/2017Cantor FitzgeraldReiterated RatingHold$65.00High
5/5/2017Jefferies Financial GroupReiterated RatingHold$49.00High
4/19/2017Cantor FitzgeraldDowngradeOverweight ➝ Neutral$60.00Low
4/7/2017CitigroupBoost Price TargetBuy$57.00 ➝ $67.00Low
3/27/2017Janney Montgomery ScottUpgradeNeutral ➝ BuyMedium
2/5/2017BTIG ResearchReiterated RatingHoldN/A
2/3/2017Bank of AmericaDowngradeNeutral ➝ Underperform$48.00N/A
1/18/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$55.00N/A
12/25/2016Cantor FitzgeraldSet Price TargetBuy$60.00N/A
11/8/2016BarclaysReiterated RatingSell$50.00N/A
(Data available from 10/19/2016 forward)

News Sentiment Rating

0.28 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/23/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/22/2021
  • 0 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/22/2021
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/21/2021
  • 3 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/21/2021
  • 12 very positive mentions
  • 37 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
8/20/2021
  • 1 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/19/2021
  • 4 very positive mentions
  • 15 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
10/19/2021

Current Sentiment

  • 4 very positive mentions
  • 15 positive mentions
  • 4 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

PerkinElmer logo
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.
Read More

Today's Range

Now: $173.32
Low: $171.37
High: $173.38

50 Day Range

MA: $180.53
Low: $166.66
High: $190.50

52 Week Range

Now: $173.32
Low: $119.95
High: $192.00

Volume

8,866 shs

Average Volume

849,960 shs

Market Capitalization

$19.43 billion

P/E Ratio

16.49

Dividend Yield

0.16%

Beta

1.1

Frequently Asked Questions

What sell-side analysts currently cover shares of PerkinElmer?

The following Wall Street analysts have issued stock ratings on PerkinElmer in the last twelve months: Citigroup Inc., Evercore ISI, KeyCorp, Needham & Company LLC, Robert W. Baird, Royal Bank of Canada, Smith Barney Citigroup, The Goldman Sachs Group, Inc., Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for PKI.

What is the current price target for PerkinElmer?

9 Wall Street analysts have set twelve-month price targets for PerkinElmer in the last year. Their average twelve-month price target is $152.77, suggesting a possible downside of 10.3%. Needham & Company LLC has the highest price target set, predicting PKI will reach $193.00 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of $49.00 for PerkinElmer in the next year.
View the latest price targets for PKI.

What is the current consensus analyst rating for PerkinElmer?

PerkinElmer currently has 1 hold rating and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PKI will outperform the market and that investors should add to their positions of PerkinElmer.
View the latest ratings for PKI.

How do I contact PerkinElmer's investor relations team?

PerkinElmer's physical mailing address is 940 WINTER STREET, WALTHAM MA, 02451. The medical research company's listed phone number is (781) 663-6900 and its investor relations email address is [email protected] The official website for PerkinElmer is www.perkinelmer.com.